Pharmacokinetics and Safety of Ambrisentan in Pediatric Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Ivy, D.
Rosenzweig, E. B.
Calderbank, M.
Coleman, B.
Miller-Reed, K.
Geppner, J.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2010年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3330
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy, safety, and pharmacokinetics of ambrisentan in Japanese adults with pulmonary arterial hypertension
    Yoshida, Shunji
    Shirato, Kunio
    Shimamura, Ryutaro
    Nakahara, Norie
    Iwase, Takayuki
    Nakajima, Hiromu
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (09) : 1827 - 1834
  • [2] Clinical Safety, Pharmacokinetics, and Efficacy of Ambrisentan Therapy in Children With Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Rosenzweig, Erika B.
    Zuckerman, Warren
    Brady, Daniela
    Calderbank, Michelle
    Ivy, D. Dunbar
    [J]. PEDIATRIC PULMONOLOGY, 2013, 48 (01) : 27 - 34
  • [3] Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    Barst, RJ
    Ivy, D
    Dingemanse, J
    Widlitz, A
    Schmitt, K
    Doran, A
    Bingaman, D
    Nguyen, N
    Gaitonde, M
    van Giersbergen, PLM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) : 372 - 382
  • [4] Pharmacokinetics of ambrisentan in a patient with Pulmonary Arterial Hypertension and a total gastrectomy
    Abston, Eric
    Farber, Harrison W.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 57
  • [5] Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
    Valerio, Christopher J.
    Kabunga, Peter
    Coghlan, John G.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 541 - 556
  • [6] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
  • [7] Ambrisentan for pulmonary arterial hypertension
    Rubin, Lewis J.
    Dufton, Christopher
    Gerber, Michael J.
    [J]. FUTURE CARDIOLOGY, 2005, 1 (04) : 425 - 432
  • [8] Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis
    Buendia, Jefferson A.
    Patino, Diana G.
    Lindarte, Erika F.
    [J]. PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1562 - 1568
  • [9] Ambrisentan (Letairis) for pulmonary arterial hypertension
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1272): : 87 - 88
  • [10] Ambrisentan for the management of pulmonary arterial hypertension
    Cheng, Judy W. M.
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (05) : 825 - 833
12345